Evofem Biosciences, Inc. Banner Image

Evofem Biosciences, Inc.

  • Ticker EVFM
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Evofem Biosciences, Inc. Logo Image
  • 51-200 Employees
  • Based in San Diego, California
Evofem Biosciences, Inc., (NASDAQ: EVFM) is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). The Company’s first commercial product, PhexxiMore™ (lactic acid, citric acid and potassium bitartrate), is the first and only vaginal pH regulator approved in the United States for the prevention of pregnancy. The Company is also advancing EVO100 into Phase 3 clinical trials for the prevention of urogenital transmission of both Chlamydia trachomatis infection (chlamydia) and Neisseria gonorrhoeae infection (gonorrhea) in women.
4.8 / 5.0 (108)

Evofem Biosciences, Inc. reports have an aggregate usefulness score of 4.8 based on 108 reviews.

Evofem Biosciences, Inc.

Most Recent Annual Report

Evofem Biosciences, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Evofem Biosciences, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!